[Synacthen depot-induced liver damage in the therapy of secondary generalized epilepsies in childhood].
D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives*; D000927:Anticonvulsants / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002648:Child; D002675:Child, Preschool; D003366:Cosyntropin / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004828:Epilepsies, Partial / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D008111:Liver Function Tests; D008297:Male
D000927:Anticonvulsants; D003366:Cosyntropin; C006418:adrenocorticotropin zinc; D000324:Adrenocorticotropic Hormone
Synacthen-Depot-induzierte Leberschädigung bei der Therapie von sekundären generalisierten Epilepsien im Kindesalter.